Tag: Eating disorders

Globally, over 22% of children and adolescents exhibit disordered eating, with prevalence increasing with age [1.5.3]. So, at what stage during adolescence is an eating disorder most likely to develop? Research points to specific periods of vulnerability for different disorders.

While most associated with childhood, pica can and does persist into adulthood, especially among those with intellectual disabilities, pregnant women, and people with certain nutritional deficiencies. This persistent and compulsive eating of non-food items requires a comprehensive, multi-disciplinary approach to address its underlying causes.

Food cravings are a universal experience, but for those with obesity or binge eating disorder, they can be relentless and overwhelming. Fortunately, advancements in pharmacology have introduced several prescription medications that can specifically target the brain's signals to help control appetite and curb cravings, but they are not a standalone magic pill.

Weight lost from diuretic misuse is not true fat loss; it is simply temporary water weight that is quickly regained. A staggering number of people, particularly those with eating disorders, misuse diuretics in a dangerous and futile attempt to lose weight.

With an FDA-issued black box warning, Wellbutrin (bupropion) is a powerful medication that isn't for everyone. Understanding who is a bad candidate for Wellbutrin is crucial to avoid serious side effects like seizures and other complications.

According to the American Association of Poison Control Centers, the rate of deaths from unintentional poisoning in children under six has dramatically decreased over the decades, leading experts to re-evaluate older interventions like ipecac. The reasons why ipecac is not used anymore are rooted in safety, efficacy, and the development of better alternatives.

For decades, syrup of ipecac was a household medicine cabinet staple recommended for accidental poisoning, but its widespread medical use has since been formally discontinued. This change reflects growing evidence that challenged the perceived benefits and highlighted the potential risks associated with using **ipecacuana** as an emetic.

Originally approved as an antiepileptic drug, topiramate has garnered attention for a range of additional applications. Beyond its well-known roles in seizure control and migraine prevention, patients and physicians are exploring **what else can topiramate be used for** to treat various off-label conditions, including mood disorders, eating disorders, and substance use disorders.

Bupropion carries a prominent black box warning regarding the increased risk of seizures in certain at-risk populations, making it crucial to identify who is not a good candidate for bupropion. A thorough medical evaluation is essential to assess these risk factors before starting this medication.

While most commonly known for treating epilepsy and preventing migraines, Topamax (topiramate) is frequently prescribed by doctors for several off-label purposes. This practice, though legal, extends the drug's application far beyond its initial FDA approval, answering the question: **What else can Topamax be used for?**